HyProCell together with 8 other selected projects is benefitting from the Common Dissemination Booster (CDB) services as a part of the CDB04-DREAM group. CDB is a relatively new service available to ongoing or completed, European, National, Regional funded Research & Innovation projects.
In the context of CDB04-DREAM, HyProCell collaborates with EU supported projects DREAM, BIONICAIRCRAFT, ENCOMPASS, LASIMM, PARADDISE, AMOS, MMTECH, and HIPERLAM. All projects are motivated by mutual interests in the field of Additive Manufacturing (AM) and are keen to promote their advances and pave the way for significant technological, industrial, environmental and social impact.
Specifically, the CDB programme of activities comprises: 1) Portfolio of dissemination results of projects; 2) Stakeholder/End-user mapping; 3) Dissemination Plan Development; 4) Dissemination Capacity building; 5) Dissemination Campaign in Practice. By encouraging the aforementioned consortia to come together, identifying common sets of results and devising joint activities the impact for the AM domain and associated industrial sectors will be greater than the sum of its parts.
One example of the CDB activities is the DREAM Summer School “Metal Additive manufacturing for real industrial applications”, which takes place in June 2019 in Italy. HyProCell is represented in the Summer School’s programme by its partner Poly-shape.
CDB is also instrumental in identifying stakeholders primarily AM specialists and prospective end-users for HyProCell’s Final Dissemination Event, which is organised jointly with the OpenHybrid project at the Manufacturing Technology Centre and Autodesk Technology Centre in the UK on 17-18 Sept 2019 and features talks, demonstrations and tours of engineering facilities.
The CDB activity is ongoing and will also pursue and support the HyProCell dissemination activities after the end of the project. This is great opportunity for HyProCell to ensure that its achievements can continue to be discussed and promoted among specialist audiences in the future.